UP!

BHE $29.86

BHE target price
29.86
0
0
Benchmark Electronics, Inc.
Type
Public
Traded as NYSE: BHE
S&P 600 Component
Industry Electronics manufacturing services
Founded 1979
Headquarters Angleton, TX
Key people
Paul Tufano, CEO
Revenue IncreaseUS$2.253 billion (FY 2011)
Operating income
DecreaseUS$841.293 million (FY 2010)
Net income
DecreaseUS$52 million (FY 2011)
Total assets IncreaseUS$1.5 billion (FY 2011)
Total equity DecreaseUS$1.115 million (FY 2011)
Number of employees
9,985(Dec 2011)
Website www.bench.com

Benchmark Electronics Inc is an EMS, ODM, and OEM company based in Angleton, TX in Greater Houston. It provides contract manufacturing services.

Initially a subsidiary of Intermedics, a medical implant manufacturer, Benchmark was sold to Electronic Investors Corporation in 1986.

The company made an IPO in 1990.

In 2007 Benchmark Electronics acquired Pemstar Inc, a contract manufacturer.

Smaller than rivals, including Flextronics and Foxconn, as of 2010 Benchmark may be increasingly seeking to move away from traditional, computing-related EMS products to more-profitable ones like medical devices.

In December 2011, founder and chairman Cary Fu promoted Gayla Delly to CEO in December 2011.

On September 16, 2016, Benchmark named Paul J. Tufano president and chief executive officer, effective immediately. He replaced Gayla Delly, who had been with Benchmark since 1996.

Benchmark Electronics's customers have included Sun Microsystems, Medtronic, EMC Corporation, iRobot, and Silicon Graphics.

While more mundane computing-related products make up the majority of its manufactures as of 2008, the company also makes telecommunications equipment and medical devices.

Benchmark Electronics has operations in ten countries.

The company has production bases in Almelo, Netherlands; Angleton, TX; Bangkok, Thailand; Brasov, Romania; Guadalajara, Mexico; Tijuana, Mexico; Huntsville, AL; Penang, Malaysia; Nashua, NH; Singapore; Suzhou, China.; and Winona & Rochester, MN.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q3 2022 2022-10-25 Future report Set alerts
Q2 2022 2022-08-03 0.50 0.50
Q1 2022 2022-04-26 0.44 0.44
Q4 2021 2022-02-03 0.48 0.48
Q3 2021 2021-10-27 0.39 0.39
Q2 2021 2021-07-28 0.27 0.27
Q1 2021 2021-04-28 0.21 0.21
Q4 2020 2021-02-04 0.34 0.34
Q3 2020 2020-10-28 0.32 0.32
Q2 2020 2020-07-29 0.07 0.07

Ratings

2016-04-27 Downgrade B. Riley Neutral $19.00
2016-04-22 Lower Price Target Needham & Company LLC Buy $24.00 to $23.00
2016-04-22 Downgrade B. Riley Buy to Neutral $28.00 to $19.00
2016-02-13 Reiterated Rating B. Riley Buy $28.00
2016-02-10 Boost Price Target RBC Capital Sector Perform $20.00 to $22.00
2016-02-10 Boost Price Target Royal Bank Of Canada Sector Perform $20.00 to $22.00
2016-02-08 Reiterated Rating B. Riley Buy $26.00
2016-02-03 Reiterated Rating B. Riley Buy $26.00
2015-10-28 Reiterated Rating B. Riley Buy $26.00
2015-10-23 Lower Price Target Citigroup Inc. $24.00 to $22.00
2015-10-23 Lower Price Target Benchmark Co. $27.00 to $24.00
2015-10-23 Lower Price Target B. Riley Buy $27.00 to $26.00
2015-10-23 Lower Price Target Needham & Company LLC Buy $27.00 to $24.00
2015-10-23 Lower Price Target RBC Capital Sector Perform $23.00 to $20.00
2015-10-20 Reiterated Rating B. Riley Buy $27.00
2015-10-14 Reiterated Rating B. Riley Buy $27.00
2015-07-29 Reiterated Rating B. Riley Buy $27.00
2015-07-24 Reiterated Rating B. Riley Buy $27.00
2015-07-23 Upgrade Raymond James Market Perform to Outperform $24.00
2015-07-23 Upgrade Raymond James Financial Inc. Market Perform to Outperform $24.00
2015-07-18 Reiterated Rating B. Riley Buy $25.00
2015-07-16 Lower Price Target RBC Capital Sector Perform $26.00 to $23.00
2015-07-13 Initiated Coverage B. Riley Buy $25.00
2015-07-02 Upgrade Citigroup Inc. Sell to Neutral
2015-04-24 Boost Price Target Citigroup Inc. Sell $21.00 to $24.00
2014-10-24 Reiterated Rating Citigroup Inc. Sell $22.00 to $21.00
2014-09-29 Upgrade Sidoti Neutral to Buy
2014-07-25 Reiterated Rating Citigroup Inc. Sell $20.00 to $22.00
2014-04-24 Upgrade Raymond James Underperform to Market Perform
2014-02-18 Upgrade Ned Davis Research Neutral to Buy
2014-02-12 Initiated Coverage Sidoti Neutral
2014-02-05 Upgrade Needham & Company LLC Hold to Buy $26.00
2013-10-25 Boost Price Target RBC Capital Sector Perform $22.00 to $24.00
2012-07-27 Reiterated Needham Buy $21 to $18.50
2010-01-19 Reiterated RBC Capital Mkts Outperform $21 to $23
2009-04-24 Reiterated Credit Suisse Neutral $12 to $11
2008-12-02 Downgrade Collins Stewart Hold to Sell
2008-10-06 Downgrade Citigroup Hold to Sell $18 to $13
2008-09-26 Reiterated RBC Capital Mkts Outperform $19 to $18
2008-07-25 Reiterated RBC Capital Mkts Outperform $21 to $19
2008-01-16 Initiated Lehman Brothers Equal-weight
2007-10-26 Reiterated RBC Capital Mkts Outperform $28 to $25
2007-10-26 Reiterated Credit Suisse Neutral $20 to $21
2007-09-19 Downgrade JP Morgan Overweight to Neutral
2016-04-27 Downgrade B. Riley Neutral $19.00
2016-04-22 Lower Price Target Needham & Company LLC Buy $24.00 to $23.00
2016-04-22 Downgrade B. Riley Buy to Neutral $28.00 to $19.00
2016-02-13 Reiterated Rating B. Riley Buy $28.00
2016-02-10 Boost Price Target RBC Capital Sector Perform $20.00 to $22.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
FU CARY T CEO 0.61%  (329699) BHE / LFUS / TDC /
DELLY GAYLA J President 0.48%  (257128) BHE / FLS /
TUFANO PAUL J 0.20%  (109663) BHE / ENS / TER /
Adam Donald Francis Chief Financial Officer 0.17%  (92706) BHE /
DORFLINGER PETER G 0.13%  (69765) BHE /
WILLIAMS CLAY C 0.09%  (48546) BHE / NOV /
King Jon J Executive Vice President 0.08%  (41720) BHE /
SCHEIBLE DAVID W 0.07%  (38383) BHE / GPK /
DAWSON MICHAEL R 0.07%  (37765) BHE /
Barrow Kenneth S General Counsel 0.07%  (37327) BHE /
STROM BERNEE DL 0.07%  (36715) BHE / MVIS /
DUNCAN DOUGLAS G 0.06%  (30524) BHE / JBHT /
LAMNECK KENNETH T 0.05%  (25018) BHE / NSIT /
JANICK JAN M Executive VP 0.04%  (22884) BHE /
COMINOS GREG W Executive Vice President 0.04%  (20747) BHE /
WEEKS LISA K Vice President 0.04%  (20163) BHE /
PETERSON SCOTT R VP & General Counsel 0.04%  (18893) BHE /
Buseman Michael D. Executive Vice President 0.03%  (16490) AVT / BHE / PLXS /
Gifford Robert K 0.02%  (10781) BHE / IM /